Work with thought leaders and academic experts in pulmonary respiratory medicine

Companies can greatly benefit from working with experts in Pulmonary and Respiratory Medicine. These professionals have in-depth knowledge and experience in diagnosing and treating respiratory conditions. They can provide valuable insights and guidance in developing new treatments, medications, and medical devices. Additionally, they can contribute to research studies, clinical trials, and data analysis. Their expertise can help companies improve patient outcomes, enhance product development, and stay at the forefront of medical advancements.

Researchers on NotedSource with backgrounds in pulmonary respiratory medicine include Garrett A. Perchetti, Research Scientist - Virology, Edoardo Airoldi, Emmanouil Mentzakis, Jeffrey Townsend, Balamurugan Tangiisuran, Mariane Vicente, Brittan S. Scales, M.P.H, Ph.D., Luke Connelly, Khoa Nguyen, Dr. Barry A. Spiering, Ph.D., Dr. Dara L. James, Richmond Ideozu, and Abiodun Adewuya.

Garrett A. Perchetti, Research Scientist - Virology

New York
Research Scientist and MD Candidate in virology with publications on infectious diseases, laboratory medicine, viral genetics, and clinical medicine
Research Interests (15)
Virology
Microbiology
Infectious Diseases
SARS-CoV-2
COVID-19
And 10 more
About
Garrett A. Perchetti is a highly accomplished research scientist in the field of virology. He received a Bachelor of Science in Microbiology and a Bachelor of Arts in Art History from the University of Washington. His interest in both science and the arts led him to pursue a career in virology, where he could combine his passion for understanding the natural world with his creative thinking skills. After completing his undergraduate studies, Garrett continued his education by earning a Medical Degree from Ross University School of Medicine in 2025. During his time in medical school, he developed a keen interest in virology and infectious diseases, which ultimately led him to specialize in this field. Garrett's educational background is complemented by his extensive experience as a research scientist. He has worked at the University of Washington School of Medicine, where he has conducted groundbreaking research on various types of viruses. His work has been published in numerous scientific journals, and he has presented his findings at international conferences. Garrett's contributions to the field of virology have been widely recognized, and he has received several awards and accolades for his work. He is known for his meticulous attention to detail, innovative thinking, and ability to collaborate effectively with other researchers. In his free time, Garrett enjoys painting, hiking, and traveling. He is also passionate about raising awareness about the importance of vaccinations and promoting public health initiatives. With his exceptional education and extensive experience, Garrett A. Perchetti is a valuable asset to the field of virology and will continue to make significant contributions in the future.

See Full Profile

Balamurugan Tangiisuran

Boston, Massachusetts, United States of America
Associate Professor in Clinical Pharmacy at Universiti Sains Malaysia
Research Interests (52)
Geriatrics
Pharmacy
Internal Medicine
Psychiatry and Mental health
Clinical Psychology
And 47 more
About
Dr. Bala brings a wealth of knowledge and expertise to his role as an Associate Professor in Clinical Pharmacy at the School of Pharmaceutical Sciences, USM. He has a proven track record of success in his field, having held key leadership positions such as Director at the Malaysian National Poison Centre and Program Chairman (Clinical Pharmacy) at the School of Pharmaceutical Sciences, USM. He holds a Bachelor of Pharmacy from USM and a PhD from Brighton and Sussex Medical School, UK. Additionally, he has been appointed as Visiting Senior Lecturer at King's College London and as a Fellow of the WHO Collaborating Centre for Drug Information at the National Poison Centre. <br> Bala's research focuses on the areas of clinical pharmacy practice and medication safety, as well as geriatric pharmacy. He has published more than 50 peer-reviewed journal articles/abstracts and has been invited as a guest speaker at numerous international and domestic scientific events. He is an experienced internal and external examiner for over 40 PhD and Master thesis and has actively reviewed manuscripts for international academic journals. Bala's teaching activities encompass both undergraduate and postgraduate-level instruction, and he has supervised the research of numerous postgraduate students. He is committed to curriculum development and has implemented innovative and interactive teaching methods to improve student learning outcomes. He has successfully graduated 24 students, including 4 PhDs, 4 MSc, and 16 Master in Clinical Pharmacy. He is dedicated to producing sustainable pharmacy education and closing the knowledge transfer gap for students. If you're interested in Clinical Pharmacy, Geriatric pharmacy, Medication Safety, Research and Education, feel free to connect and exchange ideas.

See Full Profile

Brittan S. Scales, M.P.H, Ph.D.

Highly skilled Bioinformatician and Microbiologist trained in Microbiome and NGS research
Research Interests (20)
microbiomes
marine plastic biofilms
genomics
next-generation sequencing
bioinformatics
And 15 more
About
Dr. Brittan S. Scales is a highly educated and experienced microbiologist and immunologist with a passion for infectious diseases and public health. She received her Ph.D. in Microbiology and Immunology from the University of Michigan–Ann Arbor in 2015, where she focused on studying the interactions between the lung microbiome and immune response. She also obtained her Master of Public Health degree in Infectious Diseases and Vaccinology from the University of California, Berkeley, in 2009. After completing her Ph.D., Dr. Scales worked as a Postdoctoral Researcher at the University of Michigan's Department of Microbiology & Immunology and the Leibniz Institute for Baltic Sea Research in Germany. Her research during this time focused on understanding the role of microbes in the environment and their impact on human health. Most recently, Dr. Scales worked as a Ph.D. Production Expert at ScaleAI, where she utilized her expertise in coding, math, and science to develop software solutions for various industries. She also continues to conduct research and publish papers in the fields of microbiology and immunology. Dr. Scales is dedicated to using her knowledge and skills to contribute to the prevention and treatment of infectious diseases and promote public health. She is a highly sought-after expert in her field and is committed to making a positive impact in the scientific community and beyond.

See Full Profile

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Research Interests (43)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 38 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

See Full Profile

Khoa Nguyen

San Francisco, California, United States of America
Life Sciences Expert with 18-Year Experience in Immunology, Metabolism, Neuroscience, and Biotech Entrepreuneuship
Research Interests (26)
Metabolic Physiology
Neuroimmunology
Oncology
Biochemistry
Molecular Biology
And 21 more
About
Dr. Nguyen is an experienced immunologist who specializes in studies of cellular and molecular mechanisms by which innate immunity and energy metabolic pathways regulate disease development. He has more than 15 years of experience in building innovative preclinical research programs to investigate neurological, metabolic, and inflammatory diseases as well as 7 years of experience in early stage biotechnology R&D (including drug screening, pharmacology and toxicology). His PhD thesis work at the intersection of immunology and metabolism resulted in the discovery of the critical role of innate immunity in the development of metabolic diseases. These findings were highlighted in two seminal publications in Nature and Science and a series of other publications in high profile journals such as Cell, Nature Immunology, Nature Medicine, and Nature Reviews Immunology; and are of great clinical interest with regard to the understanding of the complex pathways that contribute to metabolic syndromes as well as the development of new cures for the treatment of these disorders. In his post-graduate career, Dr. Nguyen applied his technical expertise in cellular immunology and molecular biology; and his knowledge-based strength in innate immunity and metabolism into the field of neurobiology. His pioneering neuro-immunology research program in the last seven years led to the discovery of the role of distinct metabolic pathways in innate immune cells of the brain in the development of neurological diseases. Propelled by these exciting findings was the development of drug candidates to treat neuroinflammation and neurodegeneration, which is currently moving toward clinical development stage for the treatment of Amyotrophic Lateral Sclerosis and Multiple Sclerosis by Tranquis Therapeutics, an early-stage biotechnology company, of which Dr. Nguyen is a scientific founder.

See Full Profile

Example pulmonary respiratory medicine projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on pulmonary respiratory medicine?

Development of New Inhalation Therapies

A pharmaceutical company can collaborate with a Pulmonary and Respiratory Medicine expert to develop new inhalation therapies for respiratory conditions. The researcher can provide insights on the optimal drug delivery methods, dosage forms, and formulations to ensure maximum efficacy and patient compliance.

Evaluation of Air Pollution Effects

An environmental technology company can partner with a Pulmonary and Respiratory Medicine researcher to evaluate the effects of air pollution on respiratory health. The researcher can conduct studies to assess the impact of pollutants on lung function, identify high-risk populations, and recommend mitigation strategies.

Design of Respiratory Rehabilitation Programs

A healthcare provider can collaborate with a Pulmonary and Respiratory Medicine expert to design and implement respiratory rehabilitation programs. The researcher can develop personalized exercise plans, breathing techniques, and lifestyle modifications to improve lung function and quality of life for patients with chronic respiratory conditions.

Validation of Respiratory Diagnostic Tools

A medical device company can work with a Pulmonary and Respiratory Medicine specialist to validate and refine respiratory diagnostic tools. The researcher can conduct clinical studies to assess the accuracy, reliability, and usability of the devices, ensuring they provide accurate and timely diagnoses for respiratory conditions.

Development of Telemedicine Solutions

A healthcare technology company can collaborate with a Pulmonary and Respiratory Medicine expert to develop telemedicine solutions for remote monitoring and management of respiratory conditions. The researcher can contribute to the design of user-friendly platforms, data analysis algorithms, and remote patient monitoring devices.